Document is current
Any future updates will be listed below
-
Authors
Dahir, Kathryn M.
Li, Zhiyi
Heerssen, Heather M.
Noman, Ahmed
Kim, Jeremy
Zhao, Yang
Imel, Erik A.
-
Funding
Funding for this research was provided by:
Kyowa Kirin Pharmaceutical Development
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 15 April 2025
First Online: 13 May 2025
Declarations
:
: The manuscript does not contain clinical studies, animal studies, or identifiable patient data.
: This was a retrospective, descriptive analysis utilizing de-identified data from a claims database, and therefore did not require ethical review.
: KMD has received research funding and consulted for Ultragenyx, Kyowa Kirin, Alexion, and received research funding from Regeneron and Sanofi. ZL and HH are employees of Kyowa Kirin, Inc. YZ is a former employee of Kyowa Kirin, Inc. AN is an employee of Komodo Health and JK a former employee of Komodo Health. EAI has received research funding and consulted for Ultragenyx and for Kyowa Kirin.
